Totally implantable cochlear implant promises a new era of hearing restoration

Scientists have developed a totally implantable cochlear implant that delivers hearing performance comparable to conventional devices while improving quality of life and eliminating the need for external components.

KT-253 by Kymera Therapeutics for Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 5, 2023

Age, education, and religion impact depression risk among Nigerian older adults

Research shows loneliness and physical inactivity are key factors in depression among Nigeria’s older adults, emphasizing the importance of social interactions.

November 8, 2024

Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation

Ingrezza generated $506m in revenue in Q1 2024, as per Neurocrine’s financials. Image Credit: Panchenko Vladimir / Shutterstock. The US Food and Drug Administration (FDA)

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.